11:09 AM EST, 02/12/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts started the week on a down note in Monday's trading session, declining 0.59% to 1,303.50 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical firm Genfit (GNFT) and biotech company Evaxion Biotech (EVAX), which rose 7.1% and 5.4%, respectively. They were followed by 3D printer companies Materialise (MTLS) and voxeljet (VJET), which were up 3.6% and 2.9%, respectively.

The decliners from continental Europe were led by biopharmaceutical companies argenx (ARGX) and Cellectis (CLLS), which fell 2.8% and 1.3% respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and semiconductor company Sequans Communications (SQNS), which dropped 1.1% and 1% respectively.

From the UK and Ireland, the gainers were led by biotech firms Autolus Therapeutics (AUTL) and Trinity Biotech (TRIB), which climbed 12% each. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and NuCana (NCNA), which increased 7.3% and 2.8% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm (TCBP) and pharmaceutical company AstraZeneca (AZN), which dropped 22% and 2.6% respectively. They were followed by pharmaceutical company GSK (GSK) and biopharmaceutical company Amarin (AMRN), which were down 2.2% and 1.6% respectively.

http://www.mtnewswires.com
Copyright © 2024 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.